Tirzepatide for automatic blood sugar control in type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 1 diabetes for at least 1 year
- Your body mass index (BMI) is 27 or higher
- Your most recent A1c (average blood sugar over 3 months) is above 6.5% and below 12%
- You are willing to use the Tandem Control-IQ insulin pump system and compatible insulins (not Fiasp)
- You count carbohydrates for your meal insulin doses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tirzepatide, a medicine that helps lower blood sugar and manage weight, is safe and effective for people with type 1 diabetes who are overweight or have obesity. You must already use an automated insulin pump system.
This trial tests if tirzepatide, a weekly injection, can help people with type 1 diabetes who are also overweight or obese. The goal is to see if it improves blood sugar control and supports weight loss.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
This study tests whether adding a weekly injection of tirzepatide (a drug that helps with blood sugar and weight) can improve glucose control in adults with type 1 diabetes who already use an automated insulin pump. It may help you if your blood sugar is not at target despite using a pump.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.